Filing Details
- Accession Number:
- 0001209191-23-007395
- Form Type:
- 5
- Zero Holdings:
- No
- Publication Time:
- 2023-02-06 21:10:05
- Reporting Period:
- 2021-12-31
- Accepted Time:
- 2023-02-06 21:10:05
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 850261 | Sorrento Therapeutics Inc. | SRNE | Biological Products, (No Disgnostic Substances) (2836) | 330344842 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1518466 | Kim Janda | C/O Sorrento Therapeutics, Inc. 4955 Directors Place San Diego CA 92121 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-03-15 | 3,000 | $10.42 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
Billionaire Hedge Funds
